Skip to content

The Effect of flurbiprofen axetil on postoperative immune function in patients with bone tuberculosis

The Effect of flurbiprofen axetil on postoperative immune function in patients with bone tuberculosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112190
Enrollment
Unknown
Registered
2025-11-11
Start date
2023-04-19
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone tuberculosis

Interventions

A :Twenty minutes before the end of the surgery, patients in Group A received an intravenous injection of flurbiprofen axetil at 1 mg/kg. At the conclusion of the surgery, an electronic analgesic pump
B:Twenty minutes before the end of the surgery, patients in Group A received an intravenous injection of flurbiprofen axetil at 1 mg/kg. At the conclusion of the surgery, an electronic analgesic pump

Sponsors

Shanghai Public Health Clinical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Inclusion criteria were age >=18 years of either sex with American Society of Anesthesiologists (ASA) physical status I–III; 2.A diagnosis of spinal TB meeting one of the following three criteria: typical clinical manifestations, characteristic imaging findings, or intraoperative gross findings typical of TB confirmed by histopathological identification of tuberculous lesions or laboratory bacteriological detection of M. tuberculosis; 3.Scheduling for one-stage lesion debridement, correction, bone grafting, and internal fixation; 4.No use of NSAIDs or opioids within 3 months prior to surgery.

Exclusion criteria

Exclusion criteria: 1. Combined with malignant tumors; 2. Pregnancy or lactation period; 3. Severe dysfunction of major organs; 4.Presence of surgical contraindications; 5. Comorbid mental disorders or cognitive impairment; 6. Skip spinal tuberculosis or involvement of more than three vertebrae; 7.Extensive lesion dissemination with distant flowing abscesses; 8. Complicated by severe osteoporosis; 9.Pathological fractures of spinal tuberculosis leading to acute paralysis.

Design outcomes

Primary

MeasureTime frame
Immunological Function;Inflammatory factor;

Countries

China

Contacts

Public ContactXiangjian Chen

Shanghai Public Health Clinical Center

847576705@qq.com+86 181 2115 1068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026